Eiichi Araki

1987–2024 年に発表

93
論文数
23,072
被引用数
69
h 指数
89
i10 指数

被引用数

Eiichi Araki の年別被引用数1973 年: 被引用 1 件1983 年: 被引用 1 件1987 年: 被引用 6 件1988 年: 被引用 26 件1989 年: 被引用 30 件1990 年: 被引用 15 件1991 年: 被引用 19 件1992 年: 被引用 49 件1993 年: 被引用 76 件1994 年: 被引用 87 件1995 年: 被引用 90 件1996 年: 被引用 100 件1997 年: 被引用 127 件1998 年: 被引用 102 件1999 年: 被引用 94 件2000 年: 被引用 103 件2001 年: 被引用 110 件2002 年: 被引用 155 件2003 年: 被引用 173 件2004 年: 被引用 181 件2005 年: 被引用 202 件2006 年: 被引用 171 件2007 年: 被引用 239 件2008 年: 被引用 247 件2009 年: 被引用 211 件2010 年: 被引用 225 件2011 年: 被引用 210 件2012 年: 被引用 175 件2013 年: 被引用 175 件2014 年: 被引用 174 件2015 年: 被引用 164 件2016 年: 被引用 149 件2017 年: 被引用 158 件2018 年: 被引用 161 件2019 年: 被引用 556 件2020 年: 被引用 588 件2021 年: 被引用 573 件2022 年: 被引用 429 件2023 年: 被引用 281 件2024 年: 被引用 470 件2025 年: 被引用 238 件2026 年: 被引用 5 件1974〜1982 年は被引用が無いため表示していません1984〜1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,544 件、この内訳の 27.9%日本: 引用元論文 1,122 件、この内訳の 12.3%中国: 引用元論文 855 件、この内訳の 9.4%イギリス: 引用元論文 479 件、この内訳の 5.3%ドイツ: 引用元論文 317 件、この内訳の 3.5%カナダ: 引用元論文 304 件、この内訳の 3.3%イタリア: 引用元論文 298 件、この内訳の 3.3%フランス: 引用元論文 236 件、この内訳の 2.6%オーストラリア: 引用元論文 220 件、この内訳の 2.4%デンマーク: 引用元論文 217 件、この内訳の 2.4%韓国: 引用元論文 199 件、この内訳の 2.2%インド: 引用元論文 192 件、この内訳の 2.1%
0%27.9%その他 23.3%

分野

  • Medicine56.9%
  • Biochemistry, Genetics and Molecular Biology32.5%
  • Neuroscience4.3%
  • Immunology and Microbiology1.3%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Nursing0.8%
  • その他3.2%

トピック

  • Metabolism, Diabetes, and Cancer6.2%
  • Pancreatic function and diabetes5.6%
  • Diabetes Treatment and Management5.3%
  • Adipose Tissue and Metabolism3.2%
  • Diabetes Management and Research3.1%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.8%
  • その他73.8%

共著者

全論文

検索で開く
  1. Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial

    著者: , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2018 被引用: 389

  2. Efficacy, Safety, and Tolerability of Oral Semaglutide Versus Placebo Added to Insulin With or Without Metformin in Patients With Type 2 Diabetes: The PIONEER 8 Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eleni Bekiari, Αlexandra Bargiota, Sanjay Agarwal, Banshi Saboo, Sanjay Chatterjee, Viswanathan Mohan, Shehla Shaikh, Yashdeep Gupta, Arpandev Bhattacharyya, Neeraj Manikath, Sunil Kumar, Takashi Sasaki, Takeshi Osonoi, Shuichi Fukuda, Seiki Wada, Arihiro Kiyosue, Yumiko Ide, Yukiko Onishi, Kiyokazu Matoba, Kuninobu Takai, Akira Yamauchi, Satoshi Inoue, Shizuka Kaneko, Hiroki Ikeda, Yasuharu Ohta, Akitaka Hisatomi, Takafumi Senokuchi, Hideaki Jinnouchi, Shuji Nakamura, José Roberto Lazcano Soto, Ignacio Rodríguez Briones, Paweł Bogdański, Ewa Szyprowska, Anna Modzelewska, Iwona Wozniak, S. T. Zyangirova, M. Sergeeva-Kondrachenko, Thomas R. A. Davis, Stephen P. Thomson, Juan P. Frías, Winston Gandy, Ildiko Lingvay, Kevin Pounds, Cynthia Bowman-Stroud, Michael Dempsey, David Huffman, Azazuddin Ahmed, Neil Fraser, Ramon Ortiz-Carrasquillo, D. Eric Bolster, Michael Adams, Matthew A. Hummel, Almena Free, Patricia Houser, Gerald Shockey, Otis Barnum, Kala R. Bhasker, George Mitchell Cornett, Dan Streja, William Kirby, Sean Lynd, Steven Folkerth, Samer Nakhle, Paul Norwood, Rodolfo Pérez, Brian D. Snyder, Neil Farris, Willian Litchfield, Osama Hamdy, Jean Park ほか 2 名 - Diabetes Care 2019 被引用: 282

  3. Japanese Clinical Practice Guideline for Diabetes 2019

    著者: , , , , , , , , , , - Diabetology International 2020 被引用: 543

  4. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

    著者: , , , , , , , , - Diabetes Research and Clinical Practice 1995 被引用: 3,104

  5. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus

    著者: , , , , , , , , , , , , - Diabetology International 2010 被引用: 1,771

  6. Adiponectin Stimulates AMP-Activated Protein Kinase in the Hypothalamus and Increases Food Intake

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2007 被引用: 837

  7. SIRT7 Controls Hepatic Lipid Metabolism by Regulating the Ubiquitin-Proteasome Pathway

    著者: , , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2014 被引用: 218

  8. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Churn-Ern Yip, Zubin Punthakee, Frédéric Bernier, Heather Lochnan, Vincent Woo, Thomas G. Elliott, Juan Palma, C Merino, Alfredo Danin Vargas, Ulrich Wendisch, Andreas Reichel, Jochen Seufert, Bernd Becker, Hasan Alawi, Andreas L. Birkenfeld, Christoph Hasslacher, Joerg Luedemann, Thomas Schaum, Cornelia Marck, Joachim Sauter, Ulrich Aigner, Yukiko Onishi, Hiroaki Seino, Yuichi Sato, Kiyohide Nunoi, Akira Yamauchi, Eitaro Nakashima, Hiroki Ikeda, Toshihiko Shiraiwa, Yoshimitsu Yamasaki, Hiroki Yokoyama, Kunihiko Nakamura, Masayuki Noritake, Shozo Miyauchi, Tomomi Hakoda, Yoshihide Hirohata, Atsushi Hasegawa, Yoshihide Fukumoto, Hirotaka Nagashima, Masahiro Takihata, Tetsuro Kamada, Hideaki Jinnouchi, Yuri Ono, Takayuki Watanabe, Hiroshi Ohashi, Masahiko Takai, T Seguchi, Katsuya Yamazaki, Hajime Maeda, Shingo Iwasaki, Harold W. de Valk, Adriaan Kooy, S.A.N.T. Landewé-Cleuren, Katarzyna Madziarska, Andrzej Stankiewicz, Katarzyna Wasilewska, Gottfried Rudofsky, Maciej T. Małecki, Ewa Pańkowska, Ewa Szyprowska, Monika Łukaszewicz, Lidia Tokarska, Ирина Аркадьевна Бондарь, I. V. Karpova, Ludmila Ruyatkina, Alsu Gafurovna Zalevskaya, Ruslan Sardinov, Yury Khalimov, Folke Sjöberg, Pekka Koskinen ほか 63 名 - Diabetes Care 2018 被引用: 252

  9. FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism

    著者: , , , , , , , , , , , , , , , - Nature Communications 2019 被引用: 105

  10. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein

    著者: , , , , , , , , - Nature 1991 被引用: 1,581

  11. Activation of AMP-Activated Protein Kinase Reduces Hyperglycemia-Induced Mitochondrial Reactive Oxygen Species Production and Promotes Mitochondrial Biogenesis in Human Umbilical Vein Endothelial Cells

    著者: , , , , , , , , , - Diabetes 2006 被引用: 493

  12. Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial

    著者: , , , , , , , - Atherosclerosis 2016 被引用: 213

  13. Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial

    著者: , , , , , - Journal of clinical lipidology 2017 被引用: 187

  14. AMPK and cell proliferation – AMPK as a therapeutic target for atherosclerosis and cancer

    著者: , , , - The Journal of Physiology 2006 被引用: 531

  15. Impact of mitochondrial ROS production in the pathogenesis of insulin resistance

    著者: , , , , , , , - Diabetes Research and Clinical Practice 2007 被引用: 136

  16. Brown adipocyte-derived exosomal miR-132-3p suppress hepatic Srebf1 expression and thereby attenuate expression of lipogenic genes

    著者: , , , , , - Biochemical and Biophysical Research Communications 2020 被引用: 41

  17. SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice

    著者: , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 33

  18. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene

    著者: , , , , , , - Nature 1994 被引用: 1,254

  19. Targeted Disruption of Exon 52 in the Mouse Dystrophin Gene Induced Muscle Degeneration Similar to That Observed in Duchenne Muscular Dystrophy

    著者: , , , , , , , - Biochemical and Biophysical Research Communications 1997 被引用: 150

  20. Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

    著者: , , , , , , - Journal of Atherosclerosis and Thrombosis 2018 被引用: 134

  21. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

    著者: , , , , , , , , , , , , , , , , , , , , , , - Diabetology International 2012 被引用: 897

  22. Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial

    著者: , , , , , , , , , , , , - Diabetes Care 2018 被引用: 158

  23. Targeted disruption of the Chop gene delays endoplasmic reticulum stress–mediated diabetes

    著者: , , , , , , - Journal of Clinical Investigation 2002 被引用: 866

  24. Impact of Mitochondrial ROS Production in the Pathogenesis of Diabetes Mellitus and Its Complications

    著者: , - Antioxidants and Redox Signaling 2007 被引用: 388